Connect your AI

Iris Acquisition IRAB Issuance of warrants

Issuance of warrants at other companies

Oruka Therapeutics, Inc.ORKA

$2.52M-75.7%

Ispire Technology Inc.ISPR

$91.49K—

SVC

Stellar V Capital Corp. Class A Ordinary SharesSVCC

$1.22M—

Evommune EVMN

$150—

CO2 Energy Transition Corp. Common StockNOEM

$51.75K—

ADMA BiologicsADMA

$1.4M—

Other financials

Income statement

Operating income-$144.1K—

Net income$773.9K—

Balance sheet

Cash & equivalents$854.8K—

Total debt$84.6K—

Total equity-$6.4M—

Total assets$170.4M—

Cash flow

Operating cash flow-$9.8K—

Valuation

Market cap$227.44M+0.2%

Enterprise value$226.67M—

Returns & leverage

Debt / equity-0×—

Current ratio2.9×—

Where this comes from

Reported directly by Iris Acquisition in its filing.

Tagged under the XBRL concept us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued.

The official record: Iris Acquisition ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Iris Acquisition 's issuance of warrants.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Iris Acquisition 's issuance of warrants?: Iris Acquisition (IRAB) reported issuance of warrants of $334.89K in Q1 2026.